GDTCCytoMed Therapeutics Limited
Oct 22, 2026 — Preclinical / Early Clinical Pipeline Readout
Chart by TradingViewThe schedule
- Thu22Oct
Anticipated update on proprietary CAR-gamma delta T cell therapy progress.
- Thu10Dec
Critical funding window to secure operations for FY2027 via an equity offering or strategic partnership.
- Sun14Feb
Estimated Q4 2026 and full-year earnings report detailing the forward financial roadmap.
- Thu20May
Potential regulatory IND clearance update for advancing next-generation immunotherapies.
